Переводы (Англ - Русск)

Можете перевести нижеприведенный текст и выложить на публику:

Chevrolet Traverse AWD LTZ Road Test Review

With so many options in the large crossover segment of the automotive marketplace, it is difficult to make viable choices. When those multitudes of options occur within the same family of cars – as they so often do with General Motors – well, what’s a mother to do?

GM’s Lambda platform has given us the Buick Enclave, GMC Acadia, Saturn Outlook and now the Chevrolet Traverse. The logical choice of this quartet is the Chevy. Both the Buick and GMC vehicles feel like they were built for older buyers, and who knows the future for Saturn, GM’s youngest division… it doesn’t look too pretty.

The 2009 Chevrolet Traverse AWD LTZ is what could be termed a “full dresser”. It has sufficient amenities to make driver and six passengers happy on short and long trips. What is most enticing about the Traverse is its thoughtful design and fashion-forward exterior lines. This is a clean-looking double-box machine, and design is one thing that helps the Traverse stand apart from others in the class, including its stablemates.

Можете сделать тоже самое (перевести и выложить в паблик) с этой новостью:

Hormone relaxin helps treat heart failure

Relaxin -- a naturally occurring hormone that helps women adapt to pregnancy -- is showing promise as a treatment for acute heart failure, a new study has found.

The research, conducted by scientists from the United States and Italy and presented here Sunday at an annual conference of the American College of Cardiology, said the hormone helped patients to breathe more easily.

Given in addition to standard treatment, the hormone relaxin also reduced hospital time for patients and prevented heart failure from worsening during hospitalization, the study said.

The hormone substantially relieved shortness of breath, or dyspnea, within just a few hours, an improvement that persisted over several days, the authors pointed out.

"Over 90 percent of patients with acute heart failure have dyspnea, and for the majority of these patients, it is the dyspnea that causes them to seek medical care," John Teerlink, a professor of clinical medicine at the University of California San Francisco, who authored the study.

"Consequently, improvement of dyspnea is an important and clinically relevant target of heart failure therapy."

Relaxin causes blood vessels to dilate, taking pressure off the heart and increasing blood flow to the kidneys.

Marco Metra, a professor of medicine at the University of Brescia, Italy, and a co-author of the report, said relaxin was "a promising new therapy for acute heart failure that requires further testing in additional, larger clinical trials."